147 related articles for article (PubMed ID: 31045814)
1. Radiomics features analysis of PET images in oropharyngeal and hypopharyngeal cancer.
Liao KY; Chiu CC; Chiang WC; Chiou YR; Zhang G; Yang SN; Huang TC
Medicine (Baltimore); 2019 May; 98(18):e15446. PubMed ID: 31045814
[TBL] [Abstract][Full Text] [Related]
2. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
Kuwabara H; Toriihara A; Yuasa-Nakagawa K; Toda K; Tateishi U; Yoshimura R
Head Neck; 2019 Jan; 41(1):103-109. PubMed ID: 30537436
[TBL] [Abstract][Full Text] [Related]
4. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
5. Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma.
Wong CK; Chan SC; Ng SH; Hsieh CH; Cheng NM; Yen TC; Liao CT
Medicine (Baltimore); 2019 Aug; 98(33):e16608. PubMed ID: 31415354
[TBL] [Abstract][Full Text] [Related]
6. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
7. [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.
Ishihara T; Kitajima K; Suenaga Y; Ejima Y; Komatsu H; Otsuki N; Nibu KI; Kiyota N; Takahashi S; Sasaki R
Nagoya J Med Sci; 2017 Feb; 79(1):27-36. PubMed ID: 28303058
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.
Pak K; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
Clin Nucl Med; 2015 Jan; 40(1):9-13. PubMed ID: 25423344
[TBL] [Abstract][Full Text] [Related]
9. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
[TBL] [Abstract][Full Text] [Related]
10. [Distant metastasis and incidence of second carcinomas in patients with oropharyngeal and hypopharyngeal carcinomas].
Mohadjer C; Dietz A; Maier H; Weidauer H
HNO; 1996 Mar; 44(3):134-9. PubMed ID: 8641899
[TBL] [Abstract][Full Text] [Related]
11. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
12. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
13. Volumetric MR imaging of oral, maxillary sinus, oropharyngeal, and hypopharyngeal cancers: correlation between tumor volume and lymph node metastasis.
Kimura Y; Sumi M; Ichikawa Y; Kawai Y; Nakamura T
AJNR Am J Neuroradiol; 2005 Oct; 26(9):2384-9. PubMed ID: 16219850
[TBL] [Abstract][Full Text] [Related]
14. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Truong MT; Hirata K; Yasuda K; Kano S; Homma A; Kudo K; Sakai O
BMC Cancer; 2021 Aug; 21(1):900. PubMed ID: 34362317
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
[TBL] [Abstract][Full Text] [Related]
17. Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
Cheng NM; Fang YH; Lee LY; Chang JT; Tsan DL; Ng SH; Wang HM; Liao CT; Yang LY; Hsu CH; Yen TC
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):419-28. PubMed ID: 25339524
[TBL] [Abstract][Full Text] [Related]
18. Radiomics analysis for the prediction of locoregional recurrence of locally advanced oropharyngeal cancer and hypopharyngeal cancer.
Wu TC; Liu YL; Chen JH; Chen TY; Ko CC; Lin CY; Kao CY; Yeh LR; Su MY
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1473-1481. PubMed ID: 38127096
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
Chan SC; Lin CY; Ng SH; Chang JT; Wang HM; Liao CT; Lo CW; Yen TC
Nucl Med Commun; 2010 Mar; 31(3):260-5. PubMed ID: 20072075
[TBL] [Abstract][Full Text] [Related]
20. Can alternative PET reconstruction schemes improve the prognostic value of radiomic features in non-small cell lung cancer?
Tankyevych O; Tixier F; Antonorsi N; Filali Razzouki A; Mondon R; Pinto-Leite T; Visvikis D; Hatt M; Cheze Le Rest C
Methods; 2021 Apr; 188():73-83. PubMed ID: 33197567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
